Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Does Anatomy Dictate Outcome?: Self-Expanding vs Balloon-Expandable Transcatheter Aortic Valve Replacement in Small and Extra-Small Annuli.

Cardiology in review·2026

Same author

Angiographic Characteristics and Associated Risk Factors of Premature Coronary Artery Disease among South Asians: A Systematic Review.

The American journal of cardiology·2025

Same author

Real-World Outcome of Coronary Orbital Atherectomy in Diabetic Versus Non-Diabetic Patients: A Single-Center Experience.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025

Same author

Predictors of Post-TAVR Left Bundle Branch Block: A Systematic Review and Meta-Analysis.

Journal of cardiovascular electrophysiology·2025

Same author

Racial Disparities Among Patients Undergoing Balloon-Expandable Transcatheter Aortic Valve Replacement.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Same author

Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020.

Cancer epidemiology·2025

Same journal

The Influence of Congenital Heart Defect Repair Through a Right Subaxillary Thoracotomy on Postoperative Pulmonary Function and Prognosis in Small Infants.

Reviews in cardiovascular medicine·2026

Same journal

Left Ventricular Hypertrabeculation: Historical Evolution, Diagnostic Pitfalls, and a Pragmatic Clinical Approach.

Reviews in cardiovascular medicine·2026

Same journal

Study on the Role and Mechanism of γδ T Cells in Atherosclerosis Under a High-Fat Diet.

Reviews in cardiovascular medicine·2026

Same journal

The Role of Stress Granules in Cardiovascular Diseases.

Reviews in cardiovascular medicine·2026

Same journal

Computed Tomography-Based Radiomics Provides New Insights Into Associations Between Pericoronary Fat Characteristics and Low-Density Lipoprotein Cholesterol.

Reviews in cardiovascular medicine·2026

Same journal

Association of Triglyceride-Glucose Index With In-Hospital Malignant Arrhythmias in Older Patients With Diabetes Mellitus and Left Ventricular Aneurysm: A Retrospective Study.

Reviews in cardiovascular medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Renal denervation: current status and future applications.

Sabas I Gomez, Pablo Urbandt, Nirat Beohar

¹Division of Internal Medicine and Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL.

Reviews in Cardiovascular Medicine

|February 10, 2015

Summary

This summary is machine-generated.

Renal sympathetic denervation offers a promising, low-risk treatment for resistant hypertension. This catheter-based procedure shows encouraging results in clinical trials, addressing a significant medical challenge.

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

Related Experiment Videos

Last Updated: Apr 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

Area of Science:

Cardiology
Nephrology
Interventional Cardiology

Background:

Resistant hypertension is a major clinical and economic challenge despite available antihypertensive drugs.
Limited treatment options exist for patients with uncontrolled blood pressure.
Renal sympathetic denervation has emerged as a novel therapeutic approach.

Purpose of the Study:

To review the safety and efficacy of renal sympathetic denervation for resistant hypertension.
To analyze the outcomes of completed clinical trials.
To discuss ongoing studies and future applications of this interventional technique.

Main Methods:

Review of data from completed clinical trials on renal sympathetic denervation.
Analysis of safety and efficacy endpoints.
Evaluation of ongoing research and potential future uses.

Main Results:

Two completed clinical trials demonstrated excellent safety profiles.
Encouraging outcomes were observed in patients undergoing the procedure.
The catheter-based renal sympathetic denervation appears to have minimal or low procedural risk.

Conclusions:

Renal sympathetic denervation is a viable and safe option for managing resistant hypertension.
The technique shows promise for improving blood pressure control in challenging cases.
Further research and ongoing studies will define the future role of this intervention.